Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 Diabetes

Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.

Related Keywords

Switzerland ,United States ,China ,Australia ,Canada ,Brazil ,American ,Florianmm Baeres , ,Global Medical Affairs At Novo Nordisk ,Novo Nordisk ,Scientific Sessions Of The American Diabetes Association ,Minerva Studio ,Annual Scientific Sessions ,American Diabetes Association ,Global Medical Affairs ,